Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

China flag China · Delayed Price · Currency is CNY
25.87
-0.06 (-0.23%)
Apr 29, 2026, 3:04 PM CST
32.40%
Market Cap 13.55B
Revenue (ttm) 1.09B
Net Income (ttm) 425.83M
Shares Out 523.58M
EPS (ttm) 0.81
PE Ratio 31.81
Forward PE 27.82
Dividend 0.25 (0.96%)
Ex-Dividend Date Jan 20, 2026
Volume 8,965,700
Average Volume 11,622,039
Open 26.47
Previous Close 25.93
Day's Range 25.25 - 26.47
52-Week Range 19.27 - 35.84
Beta 0.56
RSI 47.74
Earnings Date Apr 24, 2026

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 a... [Read more]

Sector Healthcare
Founded 2002
Employees 1,679
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300357
Full Company Profile

Financial Performance

In 2025, SHE:300357's revenue was 1.06 billion, an increase of 14.81% compared to the previous year's 925.39 million. Earnings were 380.94 million, an increase of 19.86%.

Financial Statements

News

There is no news available yet.